Genprex, Inc. has received an extension until October 31, 2025, to meet Nasdaq's $1.00 Minimum Bid Price and stockholders' equity requirements after failing compliance as reported on October 13, 2025. Additionally, a one-for-fifty reverse stock split will take effect on October 21, 2025, changing 50 shares into 1 share to help maintain compliance.